Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline in Neonates and Young Infants with Late-Onset Sepsis
2014-003243-34Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ceftaroline fosamil in late-onset neonatal sepsis (LONS), sepsis, Bacteremia and 2 more, sponsored by Pfizer. Primary endpoint: Safety and tolerability. Started Dec 2014; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
late-onset neonatal sepsis (LONS)sepsisBacteremiaViremiafungemia
Beyond the preview
Go deeper on 2014-003243-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003243-34.